Researchers from MUHC/McGill have found and legalized the efficiency of a speedy genome sequencing process for treating the hereditary genetic diseases.

The team was headed by Dr. Nada Jabado at the MUHC Research Institute and Dr. Jacek Majewski at McGill University. The team has authorized for the first time that a genetic disease can be identified with the help of reliable exome sequencing method.

The exome is a small part of the genome that is important for research on genetic diseases because it causes 85% of mutations.  The finding has appeared in the journal Human Mutation.

Dr. Jabado, Associate Professor of Pediatrics at MUHC's Montreal Children's Hospital elaborated that with the help of this new method, there will be no need of approaching the person with same altered gene pools, in order to determine the gene causing any disease.

The process only needs two people who are suffering or the disease and it will not even be important that two are from the same family.

Dr. Jabado added that in the method all that is required is time of two weeks and two patients for identifying any particular gene.

This method is better than the previous six or seven months time in the earlier process. This can be termed as a “positive breakthrough in genetic analysis", he added.